Oncologic Confirmatory Trial Failure Not Fatal To Accelerated Approval – FDA
Executive Summary
Cancer drugs with failed confirmatory trials may still receive accelerated approval, FDA suggested during the Oncology Drugs Advisory Committee May 12
You may also be interested in...
Accelerated Approval Needs Enforcement Mechanism For Confirmatory Trials
FDA needs to create an enforcement mechanism to ensure that companies with anticancer agents awarded accelerated approval complete confirmatory trials to show actual clinical benefit, the Oncologic Drugs Advisory Committee agreed
Accelerated Approval Needs Enforcement Mechanism For Confirmatory Trials
FDA needs to create an enforcement mechanism to ensure that companies with anticancer agents awarded accelerated approval complete confirmatory trials to show actual clinical benefit, the Oncologic Drugs Advisory Committee agreed
FDA Oncologic Cmte. More Wary About Recommending Accelerated Approval
FDA's Oncologic Drugs Advisory Committee could be more wary of recommending accelerated approval for anti-cancer agents based on limited clinical data